
1. malar j. 2015 sep 18;14:358. doi: 10.1186/s12936-015-0888-8.

nrf2-driven cd36 ho-1 gene expression circulating monocytes correlates
with favourable clinical outcome pregnancy-associated malaria.

aubouy a(1), olagnier d(2)(3), bertin g(4), ezinmegnon s(5), majorel c(6)(7),
mimar s(8), massougbodji a(9), deloron p(10), pipy b(11), coste a(12).

author information: 
(1)institut de recherche pour le développement (ird), université paul sabatier
toulouse iii, umr 152 pharma-dev, chu rangueil, bâtiment l1, 1 avenue du pr jean 
poulhès, 31059, toulouse, france. agnes.aubouy@ird.fr.
(2)institut de recherche pour le développement (ird), université paul sabatier
toulouse iii, umr 152 pharma-dev, chu rangueil, bâtiment l1, 1 avenue du pr jean 
poulhès, 31059, toulouse, france. david.olagnier@mail.mcgill.ca.
(3)lady davis institute-jewish general hospital, mcgill university, montreal,
canada. david.olagnier@mail.mcgill.ca.
(4)institut de recherche pour le développement (ird), pres sorbonne paris cité,
université paris descartes, umr 216 mère et enfant face aux infections
tropicales, paris, france. gwladys.bertin@ird.fr.
(5)centre d'etude et de recherche sur le paludisme associé à la grossesse et
l'enfance (cerpage), cotonou, benin. ezinmegnon.sem@gmail.com.
(6)institut de recherche pour le développement (ird), université paul sabatier
toulouse iii, umr 152 pharma-dev, chu rangueil, bâtiment l1, 1 avenue du pr jean 
poulhès, 31059, toulouse, france. clarisse.majorel@ird.fr.
(7)laboratoire insulaire du vivant et de l'environnement (live-ea 4243),
université de la nouvelle-caledonie (unc), nouméa, new caledonia.
clarisse.majorel@ird.fr.
(8)institut de recherche pour le développement (ird), université paul sabatier
toulouse iii, umr 152 pharma-dev, chu rangueil, bâtiment l1, 1 avenue du pr jean 
poulhès, 31059, toulouse, france. mimar.saliha1@free.fr.
(9)centre d'etude et de recherche sur le paludisme associé à la grossesse et
l'enfance (cerpage), cotonou, benin. massougbodjiachille@yahoo.fr.
(10)institut de recherche pour le développement (ird), pres sorbonne paris cité, 
université paris descartes, umr 216 mère et enfant face aux infections
tropicales, paris, france. philippe.deloron@ird.fr.
(11)institut de recherche pour le développement (ird), université paul sabatier
toulouse iii, umr 152 pharma-dev, chu rangueil, bâtiment l1, 1 avenue du pr jean 
poulhès, 31059, toulouse, france. bernard.pipy@inserm.fr.
(12)institut de recherche pour le développement (ird), université paul sabatier
toulouse iii, umr 152 pharma-dev, chu rangueil, bâtiment l1, 1 avenue du pr jean 
poulhès, 31059, toulouse, france. agnes.coste@univ-tlse3.fr.

background: pregnancy-associated malaria (pam) constitutes one severe
forms malaria infection leading fetal growth restriction high risk of
infant death. severity pathology largely attributed the
recruitment monocytes macrophages placenta evidenced by
dysregulated inflammation found placental blood. importantly, cd36(+)
monocytes/macrophages also thought participate tight control the
pro- anti-inflammatory responses following plasmodium detection through
elimination apoptotic cells malaria-infected erythrocytes, internalization
and recycling oxidized forms low-density lipoprotein collaboration with
tlr2 pro-inflammatory response. interestingly, previous work demonstrated that
cd36 expression upregulated inflammatory macrophages following stimulation
of nrf2 transcription factor, whilst pparγ pathway inhibited and
non-functional inflammatory conditions. current study examined
the possible role nrf2-driven gene expression, cd36 haem-oxygenase-1
(ho-1), pam clinical outcomes.
methods: clinical data biological samples including peripheral blood
mononuclear cells collected 27 women presenting pam. polychromatic flow
cytometry used characterize innate immune cell subpopulations quantify
cd36 protein expression level monocytes. mrna levels cd36, pparγ, nrf2 
ho-1 determined qpcr related clinical outcomes. finally, the
capacity monocytes modulate cd36 expression upon rosiglitazone or
sulforaphane treatment, two respective pparγ nrf2 activators, also
investigated.
results: cd36 receptor, mostly expressed cd14(+) circulating monocytes,
statistically correlated increased infant birth weights. interestingly, mrna
levels transcription factor nrf2 enzyme ho-1 also correlated 
lower parasitaemia increased infant birth weight, pparγ mrna levels did
not. finally, monocytes isolated low infant birth weight pregnant women were
capable up-regulating cd36 via nrf2 pathway ex vivo.
conclusions: altogether results suggest nrf2-driven cd36 ho-1
expression innate immune cells could contribute protective and
detoxifying mechanism pam. powered mechanistical studies are
however needed strengthen conclusions study.

doi: 10.1186/s12936-015-0888-8 
pmcid: pmc4575452
pmid: 26385579  [indexed medline]

